Suspected Text Similarity: Aromatase Inhibition and Capecitabine Combination as 1st or 2nd Line Treatment for Metastatic Breast Cancer – a Retrospective Analysis. Asian Pac J Cancer Prev. 2015;16(15):6359-64.

Questionable Paper: Shankar A, Roy S, Rath GK, Julka PK, Kamal VK, Malik A, Patil J, Jeyaraj PA, Mahajan MK. Aromatase Inhibition and Capecitabine Combination as 1st or 2nd Line Treatment for Metastatic Breast Cancer – a Retrospective Analysis. Asian Pac J Cancer Prev. 2015;16(15):6359-64.

Abhishek Shankar¹*, Shubham Roy2 , Goura Kishor Rath¹, Pramod Kumar Julka¹, Vineet Kumar Kamal4 , Abhidha Malik¹, Jaineet Patil³, Pamela Alice Jeyaraj³, Manmohan K Mahajan³

1 Department of Radiation Oncology, Dr. B.R.Ambedkar Institute Rotary Cancer Hospital,

4 Department of Bio-Statistics, All India Institute of Medical Sciences,

2 Department of Paediatrics, VMMC and Safdarjung Hospital, Delhi,

3 Department of Radiation Oncology, Christian Medical College, Ludhiana, India

*For correspondence: doc.abhishankar@gmail.com

Original Paper: Milani A, Geuna E, Mittica G, Valabrega G. Overcoming endocrine resistance in metastatic breast cancer: Current evidence and future directions. World J Clin Oncol. 2014 Dec 10;5(5):990-1001. doi: 10.5306/wjco.v5.i5.990.

Questionable Journal: Asian Pacific Journal of Cancer Prevention

Matching Summary Software Support: iPlagiarism.org

Matching Summary
Software Support: iPlagiarism.org

Continue reading